[Elsevier] Long-term Safety And Tolerability Of Acoramidis (AG10) In Symptomatic Transthyretin Amyloid Cardiomyopathy: 4-year Update From An Ongoing, Phase 2, Open-label Extension Study

Fatima.Mo Post time 2026-3-7 08:09:56 | Show all posts |Read mode
This post will be closed automatically in 2026-03-10 08:09
Reward10points

journalㄩJournal of Cardiac Failure

AuthorsㄩAhmad Masri; Mandar Aras; Rodney H. Falk; Martha Grogan; Daniel Jacoby; Mathew S. Maurer; Sanjiv J. Shah; Ronald Witteles; Paul W. Wong; Alan X. Ji; Jing Du; Suresh Siddhanti; Uma Sinha; Jonathan C. Fox; Daniel P. Judge

Published dateㄩ2024-1-

DOIㄩ10.1016/j.cardfail.2023.10.251

PDF linkㄩhttps://www.sciencedirect.com/sc ... 071916423006280/pdf

Article linkㄩhttps://doi.org/10.1016/j.cardfail.2023.10.251

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
armie Post time 2026-3-7 08:09:57 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    510


Return to the list